Condition: Liver carcinoma
rs10272859 in
CDK14 gene and
Liver carcinoma
PMID 29246937 2018 This index rs10272859 also showed significant association with the survival of HCC patients.<b>Conclusions:</b> Our findings highlight a novel locus at 7q21.13 conferring both susceptibility and prognosis to HBV-related HCC, and suggest the <i>CDK14</i> gene to be the functional target of the 7q21.13 locus.<i>Clin Cancer Res; 24(4); 906-15.©2017 AACR</i>.
rs1057519881 in
CDKN2A gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs144479038 in
CDKN3 gene and
Liver carcinoma
PMID 10987270 2000 Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.
rs3096380 in
CMTR2 gene and
Liver carcinoma
PMID 30945673 2019 Genomewide association study for C-reactive protein in Indians replicates known associations of common variants.
PMID 30945699 2019 Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma.
rs1057519956 in
CNOT9 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519884 in
CREBBP gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519886 in
CTNNB1 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
PMID 25157968 2014 Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
rs1012068 in
DEPDC5 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs77236434 in
DLC1 gene and
Liver carcinoma
PMID 28662289 2017 Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.
rs1057519897 in
FGFR1 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs11554273 in
GNAS gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs455804 in
GRIK1 gene and
Liver carcinoma
PMID 22807686 2012 The association at rs455804 implicates GRIK1 as a novel susceptibility gene for HBV-related HCC, suggesting the involvement of glutamate signaling in the development of HBV-related HCC.
rs11866328 in
GRIN2A gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs2523961 in
HLA-A;MICD gene and
Liver carcinoma
PMID 29784950 2018 Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
rs3077 in
HLA-DPA1 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs2295119 in
HLA-DPA2 gene and
Liver carcinoma
PMID 29784950 2018 Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
rs9277535 in
HLA-DPB1 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs2040406 in
HLA-DQA1 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
PMID 22807686 2012 GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.
rs9272535 in
HLA-DQA2;LOC107986589;HLA-DQA1 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs9274407 in
HLA-DQB1 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs7453920 in
HLA-DQB2 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs104894230 in
HRAS;LRRC56 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs121913499 in
IDH1 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519906 in
IDH2 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs17401966 in
KIF1B gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
PMID 20676096 2010 We identified one intronic SNP (rs17401966) in KIF1B on chromosome 1p36.22 that was highly associated with HBV-related HCC and confirmed this association in five additional independent samples, consisting of 1,962 individuals with HCC, 1,430 control subjects and 159 family trios.
rs17851045 in
KRAS gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs4678680 in
LOC105377022 gene and
Liver carcinoma
PMID 21105107 2010 Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs104894226 in
LRRC56;HRAS gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs121913675 in
MET gene and
Liver carcinoma
PMID 9927037 1999 Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas.
rs2596542 in
MICA-AS1;MICA gene and
Liver carcinoma
PMID 21499248 2011 Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
rs567116808 in
MTUS1 gene and
Liver carcinoma
PMID 16650523 2006 Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.
rs1057519922 in
NFE2L2 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs11554290 in
NRAS gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs34675408 in
OSMR gene and
Liver carcinoma
PMID 30945673 2019 Genomewide association study for C-reactive protein in Indians replicates known associations of common variants.
PMID 30945699 2019 RESULTS A prognostic model including 5 SNPs (rs10893585, rs2431, rs34675408, rs6078460, and rs6766361) was established and exhibited high predictive accuracy for HCC prognosis.
rs913493 in
PCDH9 gene and
Liver carcinoma
PMID 30945699 2019 Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma.
PMID 30945673 2019 Genomewide association study for C-reactive protein in Indians replicates known associations of common variants.
rs104886003 in
PIK3CA gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
PMID 15608678 2005 PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
rs2896019 in
PNPLA3 gene and
Liver carcinoma
PMID 29385134 2018 Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
rs1057519958 in
RXRA gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs2143571 in
SAMM50 gene and
Liver carcinoma
PMID 29385134 2018 Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
rs754688962 in
SF3B1 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519959 in
SF3B2 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs10931481 in
STAT4 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
PMID 23242368 2013 The risk allele G at rs7574865 was significantly associated with lower mRNA levels of STAT4 in both the HCC tissues and nontumor tissues of 155 individuals with HBV-related HCC (P(trend) = 0.0008 and 0.0002, respectively).
rs1554040964 in
TERT gene and
Liver carcinoma
PMID 23000435 2013 Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis.
PMID 28677271 2017 Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
rs17047200 in
TLL1 gene and
Liver carcinoma
PMID 28163062 2017 We found a strong association between the SNP rs17047200, located within the intron of the tolloid like 1 gene (TLL1) on chromosome 4, and development of HCC; there was a genome-wide level of significance when the results of the GWAS and replication study were combined (odds ratio, 2.37; P = 2.66 × 10<sup>-8</sup>).
rs1057519747 in
TP53 gene and
Liver carcinoma
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
PMID 15004724 2004 Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line.
PMID 25157968 2014 Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
rs1110446 in
TRIM31 gene and
Liver carcinoma
PMID 29784950 2018 Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
rs9267665 in
ZBTB12;C2;CYP21A2 gene and
Liver carcinoma
PMID 23242368 2013 Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.